Amoxicillin-Clavulanate Dosing in Pediatric Patients
The standard dosage of amoxicillin-clavulanate for pediatric patients is 45 mg/kg/day of the amoxicillin component divided into 3 doses or 90 mg/kg/day divided into 2 doses for β-lactamase producing organisms. 1
Age-Based Dosing Recommendations
Neonates and Infants <12 weeks (<3 months)
- 30 mg/kg/day divided every 12 hours, based on the amoxicillin component 2
- Use of the 125 mg/5 mL oral suspension is recommended for this age group 2
Patients ≥12 weeks (≥3 months)
- For otitis media, sinusitis, lower respiratory tract infections, and more severe infections:
- 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours 2
- For less severe infections:
- 25 mg/kg/day divided every 12 hours or 20 mg/kg/day divided every 8 hours 2
- The twice-daily regimen is preferred as it is associated with significantly less diarrhea 2
Patients Weighing ≥40 kg
- Should be dosed according to adult recommendations 2
- The 250 mg/125 mg tablets should not be used until the child weighs at least 40 kg due to different amoxicillin to clavulanic acid ratios 2
High-Dose Regimen
- High-dose amoxicillin-clavulanate is defined as 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in two divided doses for children 3
- This regimen is recommended for areas with high prevalence of penicillin-resistant Streptococcus pneumoniae (>10%) 1
- The high-dose formulation provides a 14:1 ratio of amoxicillin to clavulanate in an oral suspension 3
- This higher dose is particularly important for treating acute otitis media caused by penicillin-intermediate and -resistant S. pneumoniae 4
Specific Indications and Dosing
Acute Otitis Media
- For recurrent or persistent AOM after failure of amoxicillin alone, high-dose amoxicillin/clavulanate (90 mg/kg/day of amoxicillin component) is recommended 4, 5
- Treatment duration should be 10 days 2
- The high-dose formulation has shown similar tolerability to conventional twice-daily formulation (45/6.4 mg/kg/day) 4
Respiratory Tract Infections
- For β-lactamase producing H. influenzae, amoxicillin-clavulanate at 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses is recommended 3
- The standard pediatric dose of 40-45 mg/kg/day may be inadequate to effectively eradicate resistant S. pneumoniae, particularly during viral coinfection 6
Important Clinical Considerations
- Twice-daily dosing is associated with better compliance and less diarrhea than three-times-daily dosing 4
- A reduced-clavulanate formulation (80 mg amoxicillin/2.85 mg clavulanate/kg/day) may be associated with fewer side effects (particularly diaper dermatitis) without reducing clinical efficacy 7
- Serum levels of amoxicillin increase linearly with the dose, and the difference in the incidence of adverse effects between lower and higher doses is generally negligible 3
- Common adverse effects include diarrhea, nausea, vomiting, and rash 3
Dosage Adjustments
- Patients with impaired renal function generally do not require a reduction in dose unless the impairment is severe 2
- For children with glomerular filtration rate <30 mL/min, dosage adjustment is necessary 2
By following these dosing guidelines, clinicians can optimize treatment outcomes while minimizing adverse effects in pediatric patients requiring amoxicillin-clavulanate therapy.